Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 0 | 5 | 0 | 7 | 0 |
| Gross Profit | 0 | 3 | 0 | 7 | 0 |
| Operating Expenses | 5,720 | 6,180 | 5,720 | 5,880 | 4,500 |
| Operating Income | -5,720 | -6,175 | -5,720 | -5,873 | -4,500 |
| Interest Expense | 0 | 70 | 0 | 0 | 0 |
| Other Income | 280 | 435 | 450 | 513 | 560 |
| Pre-tax Income | -5,440 | -5,810 | -5,270 | -5,360 | -3,940 |
| Net Income Continuous | -5,445 | -5,797 | -5,275 | -5,369 | -3,949 |
| Net Income | $-5,445 | $-5,797 | $-5,275 | $-5,369 | $-3,949 |
| EPS Basic Total Ops | -45.62 | -50.42 | -45.62 | -45.62 | -33.61 |
| EPS Basic Continuous Ops | -46.58 | -49.63 | -45.32 | -46.24 | -34.01 |
| EPS Diluted Total Ops | -45.62 | -50.42 | -45.62 | -45.62 | -33.61 |
| EPS Diluted Continuous Ops | -46.58 | -49.63 | -45.32 | -46.24 | -34.01 |
| EBITDA(a) | $-5,670 | $-6,115 | $-5,670 | $-5,823 | $-4,450 |